There were 1,866 press releases posted in the last 24 hours and 442,525 in the last 365 days.

Medivation Announces Participation at Upcoming Investor Conference


/EINPresswire.com/ -- SAN FRANCISCO, CA -- (Marketwired) -- 11/06/15 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:

  • David Hung, M.D., president and chief executive officer, and Rick Bierly, chief financial officer, will participate in a fireside chat at the Jefferies Autumn 2015 Global Healthcare Conference on Thursday, November 19, at 8:00am GMT at The May Fair Hotel, London

Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm. A replay of the webcast will be available on the Company's website for 30 days following the live event.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at http://www.medivation.com

Contacts:
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900


Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.